We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Targeting Headaches and Tumors with Nano-Submarines

News   Jul 20, 2018 | Original story from Johannes Gutenberg University Mainz

 
Targeting Headaches and Tumors with Nano-Submarines

Combining a tiny drug capsule -- a nanocarrier -- with antibodies under acidic conditions results in the antibodies attaching to the drug carrier in a stable way. This makes it possible for nanocarriers to target diseased tissue. Credit: Stefan Schuhmacher

 
 
 

RELATED ARTICLES

Ebola Patients Have a 90% Survival Rate After Injection With New Drugs

News

Two Ebola drugs have proven so effective in a clinical trial that researchers will make the treatments available to anyone infected with the virus in the Democratic Republic of the Congo, where Ebola has killed nearly 1,900 people over the past year.

READ MORE

Mastering the Tricky Task of Measuring Tiny Nanoparticles

News

Researchers have determined that measuring the range of sizes in nanoparticles — instead of just the average particle size — is optimal for most applications.

READ MORE

Nanoparticle Drugs Pass Through Lymphatics to Destroy Metastases

News

Researchers have developed a strategy to target metastases residing in the lymph nodes, destroying them before they can cause cancer at other locations.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE